346 related articles for article (PubMed ID: 7612234)
1. Principles for adoptive T cell therapy of human viral diseases.
Riddell SR; Greenberg PD
Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
[TBL] [Abstract][Full Text] [Related]
2. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific T cells for the treatment of infections after transplantation.
Einsele H
Hematol J; 2003; 4(1):10-7. PubMed ID: 12692515
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
5. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
6. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
7. Genetic modification of T-cell clones for therapy of human viral and malignant diseases.
Greenberg PD; Finch RJ; Gavin MA; Kalos M; Lewinsohn DA; Lonergan M; Lord JD; Nelson BH; Ohlén C; Sing AP; Warren EH; Yee C; Riddell SR
Cancer J Sci Am; 1998 May; 4 Suppl 1():S100-5. PubMed ID: 9619278
[No Abstract] [Full Text] [Related]
8. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
9. Strong and sustained effector function of memory- versus naïve-derived T cells upon T-cell receptor RNA transfer: implications for cellular therapy.
Thomas S; Klobuch S; Besold K; Plachter B; Dörrie J; Schaft N; Theobald M; Herr W
Eur J Immunol; 2012 Dec; 42(12):3442-53. PubMed ID: 22930221
[TBL] [Abstract][Full Text] [Related]
10. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
13. Defining parameters for successful immunocytotherapy of persistent viral infection.
Berger DP; Homann D; Oldstone MB
Virology; 2000 Jan; 266(2):257-63. PubMed ID: 10639312
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of murine cytomegalovirus-immune lymph node cells prevents retinitis in T-cell-depleted mice.
Lu Y; Bigger JE; Thomas CA; Atherton SS
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):301-10. PubMed ID: 9040462
[TBL] [Abstract][Full Text] [Related]
15. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
[TBL] [Abstract][Full Text] [Related]
17. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
18. CMV-specific immunotherapy.
Einsele H; Hebart H
Hum Immunol; 2004 May; 65(5):558-64. PubMed ID: 15172457
[TBL] [Abstract][Full Text] [Related]
19. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
Ellefsen K; Harari A; Champagne P; Bart PA; Sékaly RP; Pantaleo G
Eur J Immunol; 2002 Dec; 32(12):3756-64. PubMed ID: 12516570
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
